Publications
Publications, Books, Book Chapters and Reviews by Prof. Marcus Maurer, MD
Use: Start with an overview of all publications. Use tag links to list selected documents or to list an entire category, e.g. Original Work, Books, Book Chapters, Reviews. If you know what you are looking for, enter this term in the search field.
- Order by:
- Title
- Date added
- Download count
- [r.173] Expert consensus on the use of omalizumab in chronic urticaria in China (235)
- [bc.42] Omalizumab in the treatment of urticaria (133)
- [r.143] Treatments of cold urticaria: a systematic review (12)
- [r.152] How to treat patients with chronic spontaneous urticaria with omalizumab: questions and answers (11)
- [o.341] Real-life treatment of cholinergic urticaria with omalizumab (4)
- [o.386] Response of omalizumab in normocomplementemic urticarial vasculitis (4)
- [r.161] Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA), Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI), Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI), Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI), Österreichische Gesellschaft für Pneumologie (ÖGP) in co-operation with the German, Austrian, and Swiss ARIA groups, and the European Academy of Allergy and Clinical Immunology (EAACI) (4)
- [o.334] Total IgE levels are linked to the response of chronic spontaneous urticaria patients to omalizumab (3)
- [o.297] The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change (3)
- [o.261] Effect of omalizumab on angioedema in H1-antihistamine resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial (3)
- [r.169] Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell-mediated angioedema (3)
- [o.414] Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria (3)
- [o.180] Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis (2)
- [o.339] Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double‐blind, placebo‐controlled study (2)
- [o.298] Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data (2)
- [o.394] Anaphylaxis to mepolizumab and omalizumab in a single patient – is polysorbate the culprit? (2)
- [r.162] Total IgE as marker in chronic spontaneous urticaria (2)
- [o.421] Omalizumab in chronic inducible urticaria: a real-life study of efficacy, safety, predictors of treatment outcome and time to response (2)
- [o.427] Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria (2)
- [r.094] Omalizumab for the treatment of chronic urticaria (1)
(Last update: 05.2024)
Number of original publications in peer-reviewed journals: | 599 |
Number of reviews in peer-reviewed journals: | 217 |
Number of publications (original work and reviews) in peer-reviewed journals: | 816 |
Cumulative IF for original publications in peer-reviewed journals: | 4346.09 |
Cumulative IF for reviews in peer-reviewed journals: | 1699.02 |
Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 6060.11 |
Total number of citations: 36,239, h-index: 98 (Web of Science May 2024) | 36239 |
Download-Information
To be able to download the offered contents, you have to login. If you do not know the login, please write me your request.